Fifth vaccine set to enter Phase III clinical trials
A fifth COVID-19 vaccine is scheduled to enter a Phase III clinical trial in the coming weeks with 30,000 participants in the United States and Mexico. Read More »
A fifth COVID-19 vaccine is scheduled to enter a Phase III clinical trial in the coming weeks with 30,000 participants in the United States and Mexico. Read More »
Pharmacists "Again Prepared to Step Forward and Serve as Essential Health Care Providers" Read More »
The Food and Drug Administration Advisory panel approved the Pfizer-BioNTech COVID-19 vaccine Dec. 10, greenlighting vaccination efforts for priority groups including frontline health care workers, pharmacists and residents at long-term care facilities, the American Pharmacists Association reports. Read More »
The leaders of 18 pharmacy organizations today issued the following statement following the Food and Drug Administration's approval of the first Emergency use Authorization for the COVID-19 vaccine. Read More »
Action from the U.S. Department of Health and Human Services (HHS) and Food and Drug Administration (FDA) has been challenged by the Pharmaceutical Research and Manufacturers of America (PhRMA), Partnership for Safe Medicines (PSM) and Council for Affordable Health Coverage (CAHC) for letting drugs from Canada into the country without the authorization of manufacturers' oversight. Read More »
The Food and Drug Administration (FDA) confirmed that all dispensers such as pharmacies will have to meet requirements that go into effect on Friday, Nov. 27, regardless of the American Pharmacists Association's (APhA) concerns that not all of the Drug Supply Chain Security Act requirements are undermined by COVID-19 pandemic responses. Read More »
While there are concerns about the unforeseen health impacts of a vaccine for COVID-19, a coalition of pharmaceutical companies has joined together to build confidence in the process and end result. Read More »
U.S. Surgeon General Jerome Adams recently released a Call to Action to Control Hypertension, noting the important role of pharmacists beyond simply dispensing prescriptions. Read More »
Several U.S. House Representatives fought to protect access for patients to affordable medicines and the Association for Accessible Medicines (AAM) applauds their effort, according to a news release. Read More »
The American Pharmacists Association (APhA) has partnered with Washington State University College of Pharmacy and Pharmaceutical Sciences to launch a program to prepare pharmacists to meet education requirements to administer vaccinations to children ages three to 18, according to a news release on the APhA's website. Read More »
The U.S. health care system saved $313 billion in 2019 from generics and biosimilar drugs, including $96 billion in Medicare savings and $48.5 billion in savings to Medicaid. Read More »
Pharmaceutical Research and Manufacturers of America (PhRMA) president and CEO Stephen J. Ubl has issued a statement regarding the administration's choice of the most favored nation policy. Read More »
Pharmaceutical Research and Manufacturers of America President and CEO Stephen Ubl said the biopharmaceutical industry is confident it will beat COVID-19 as it ensures the highest standards in research, testing and manufacturing a vaccine for the virus. Read More »
Dan Leonard formerly president and CEO of the National Pharmaceutical Council (NPC) has been named new president and CEO of the Association for Accessible Medicines, members of the AAM board announced on Aug. 25. Read More »
This year's We Work for Health Champion Awards honors many individuals that have done tremendous work in the health care industry this year, especially with COVID-19 presenting a new and unique situation. Read More »
The American Pharmacists Association and 12 other pharmacy organizations told a special committee of the National Academies of Science, Engineering and Medicine (NASEM) that pharmacists should be given tier 1 priority status in the allocation and distribution of COVID-19 vaccine(s). Read More »
The high costs of medical care are well-documented, but those battling significant illnesses have found a measure of economic relief through manufacturer cost-sharing assistance programs. Read More »
The push for a COVID-19 vaccine is “remarkably positioned to succeed,” Jenny Bryant, executive vice president of policy and research for the Pharmaceutical Research and Manufacturers of America (PhRMA), said. Read More »
In a recent response to President Donald Trump's executive order regarding essential medicines, the Association for Accessible Medicines highlighted the importance of generic and biosimilar medicines for ensuring the health and well-being of U.S. residents. Read More »
A recent letter to Congressional leaders from a coalition headed by the National Forum for Heart Disease and Stroke Prevention urges Congress to include payments for front-line pharmacists in the next COVID-19 relief package by designating them as providers under Medicare Part B. Read More »